Endpoints: Critical Preclinical Markers in Extracellular Protein Degradation Assays
In this GEN webinar, Shyra Gardai, PhD, will demonstrate the potential of the novel extracellular degrading platform, EpiTACs, using the development of bispecific antibodies to degrade the canonical receptor tyrosine kinase epidermal growth factor receptor as a case study
Biologics Manufacturing: Maximizing Productivity Using Process Intensification
In this GEN webinar, our expert speakers will share their journey of implementing intensified technologies and its potential to improve the efficiency and cost-effectiveness of biologics manufacturing.
Alzheimer’s Disease: Early Detection and Multi-Etiology Insights from Blood-Based Immunoassays
In this GEN webinar, our expert speaker, Dr. Sterling Johnson, will discuss multi-plex blood biomarker assays, new discoveries in AD research from a large-scale study, and opportunities for early intervention during the presymptomatic phase of the disease.
Therapeutic Antibody Discovery: Selecting Effective Candidates for Emerging Viral Threats
In this GEN webinar, , researchers from Vanderbilt University Medical Center will present methods for rapidly isolating and characterizing human monoclonal antibodies, particularly those targeting the SARS-CoV-2 spike protein.
Strategies for Screening and Characterizing Targeted Covalent Inhibitors from Discovery to IND
In this GEN webinar, our speakers will introduce innovative approaches to screen for covalent binders, including the use of covalent DNA-encoded libraries (DELs), high throughput screening library collections, and covalent fragment libraries for fragment-based hit generation.
Navigating GMP Manufacturing Workflows for RNA-LNP Therapeutics
In this GEN webinar, David Sokolowski and Ingram Vargas will share strategies for successfully navigating evolving manufacturing workflows, processes, and technologies for RNA vaccines and therapies.
Navigating the Regulatory and Manufacturing Realities of mRNA Therapeutic Development
In this GEN webinar, a panel of industry experts will explore the evolution of mRNA technology and the innovations that are driving the conversation around manufacturing setups and regulatory decisions.
Spatiotemporal Omics: Advances to Integrate Multi-Omics Data
In this GEN webinar, Mu-ming Poo, PhD, Miguel Esteban, PhD, and Jan Mulder will discuss some of the wide-ranging applications of spatial technology using examples that demonstrate the technology’s ability to provide a more fine-grained picture of cells’ underlying molecular mechanisms in areas such as digital pathology and developmental biology.
Innovative Solutions for Enhancing Biotherapeutic Expression and Development
In thi's GEN webinar, Jin Lu, PhD, discusses latest additions to the GS® expression toolbox and shares strategies for using these technologies to drive successful development of your molecule from discovery through to commercial supply.
GEN Chat: Complete Genomics’ Rade Drmanac Talks NGS Then and Now
In this inaugural GEN chat webinar, Rade Drmanac, PhD, sat down with Dr. Julianna LeMieux (Deputy Editor in Chief, GEN) for a candid conversation about all things next-gen sequencing (NGS).
Fireside Chat: Spatial Biology Trends and Decoding Cancer Insights
In this GEN fireside chat, a distinguished panel of experts will discuss important trends and breakthrough topics in spatial biology and AI.
Overcoming Sterility Challenges in Cell and Gene Therapy Manufacturing
In this GEN webinar, Troy Ostreng will discuss CPC’s suite of connector solutions for addressing sterility, chemical compatibility, and ultra-low temperature challenges in the CGT development process, and how they ensure long-term success.
Harnessing the Power of g-NK Cells to Treat Hematologic Malignancies
In this GEN webinar, Mark Frohlich, MD, CEO of Indapta Therapeutics, discussed the company’s approach to developing a universal, allogeneic g-NK cell therapy that improves the cytotoxicity of antibody therapy in cancer.
Modeling Clonal Evolution in Hematopoietic Malignancies
In this GEN webinar, Robert Bowman, PhD, from the Perelman School of Medicine will discuss his lab’s approaches for modeling clonal evolution in mouse models of disease.
Strategies for Developing and Manufacturing Bispecific Antibodies and Fusion Proteins
In this GEN webinar, our speakers Xiaoyue Chenn, PhD, and Yifeng Li, PhD, will present WuXi Biologics’ suite of advanced solutions for overcoming obstacles associated with the development and manufacturing of complex biologics.
Characterizing AAV Charge Heterogeneity Using High-Resolution icIEF Fractionation with LC-MS Analysis
In this GEN webinar, our speakers Xiaoping Zeng He, PhD, and Chris Heger, PhD, will discuss icIEF technology and its application to protein charge analysis in AAV gene therapy development.